Trevi Therapeutics, Inc. (TRVI) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -16.69M | -7.63M | -10.88M | -10.1M | -13.48M | -9.55M | -9.56M | -8.68M | -10.47M | -6.36M | -7.28M | -9.88M | -8.2M | -6.33M | -8.58M | -6.18M | -7.09M | -6.23M | -7.24M | -7.9M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -23.83% | 20.09% | -13.86% | -16.33% | -28.76% | -50.18% | -31.28% | 12.07% | -27.69% | -0.44% | 15.12% | -59.89% | -15.58% | -1.64% | -18.44% | 21.8% | 6.41% | 30.2% | -3.93% | 6.38% |
| Net Income | -13.19M | -8.32M | -11.8M | -12.3M | -10.34M | -11.41M | -13.24M | -12.35M | -10.9M | -7.82M | -7.7M | -7.14M | -6.4M | -5.5M | -8.27M | -8.05M | -7.33M | -8.52M | -7.25M | -9.79M |
| Depreciation & Amortization | 34K | 31K | 38K | 38K | 37K | 38K | 36K | 38K | 35K | 35K | 35K | 34K | 19K | 15K | 9K | 8K | 11K | 12K | 13K | 12K |
| Stock-Based Compensation | 2.19M | 1.35M | 1.24M | 1.38M | 1.21M | 917K | 821K | 1.13M | 723K | 534K | 530K | 0 | 578K | 501K | 569K | 520K | 737K | 540K | 540K | 745K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23K | -472K | 0 | 0 | 0 | 0 | 0 | 0 | -53K | 5K | -40K |
| Other Non-Cash Items | -326K | -422K | -190K | -273K | -283K | -99K | -324K | -223K | -261K | 134K | 119K | 73K | -580K | -460K | -74K | 207K | 165K | 157K | 151K | 521K |
| Working Capital Changes | -5.4M | -274K | -169K | 1.05M | -4.1M | 1.01M | 3.15M | 2.73M | -62K | 736K | 207K | -2.84M | -1.81M | -882K | -814K | 1.14M | -676K | 1.64M | -695K | 658K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -1.48M | 123K | -282K | 1.55M | -1.99M | 1.8M | 130K | -618K | 294K | 627K | -170K | -592K | -914K | 536K | -1.47M | 2.05M | -1.11M | 615K | -1.25M | 2.69M |
| Cash from Investing | 16.96M | -30.61M | -50.94M | -2.61M | -9.95M | -23.87M | 7.67M | 2.77M | -8.09M | 12.85M | 17.98M | 19.64M | 8.96M | -48.31M | -4.85M | -54.22M | 0 | 0 | 0 | 0 |
| Capital Expenditures | -102K | 0 | -12K | 0 | 0 | -7K | 0 | -28K | 0 | -22K | -18K | -40K | -57K | -116K | -43K | 0 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.2M | -1.96M | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 431K | 167K | 0 | 383K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.2M | 1.96M | 72K | 0 | 0 | 0 | 0 |
| Cash from Financing | 222K | 284K | 1.63M | 110.39M | 8.71M | 51.47M | 4.98M | 5.07M | -28K | -54K | 1.51M | -7.66M | -1.7M | 652K | 55.3M | 55.98M | -625K | 13.74M | 134K | 2.75M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | -11K | -31K | -32K | -31K | -32K | -32K | -31K | -7.66M | -1.75M | -1.75M | -1.75M | -1.75M | -583K | 0 | 0 | 0 |
| Equity Issued (Net) | 222K | -441K | 0 | 110.39M | 0 | 51.45M | 4.85M | 248K | 4K | -1.73M | 1.54M | 28K | 0 | 2.4M | 51.18M | 51.83M | -42K | 13.68M | 533K | 2.79M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 725K | 1.63M | 0 | 8.72M | 49K | 163K | 4.85M | 0 | 1.71M | 0 | -32K | 47K | 2K | 5.87M | 5.9M | 0 | 63K | -399K | -41K |
| Net Change in Cash | 498K | -37.95M | -60.19M | 97.68M | -14.72M | 18.05M | 3.09M | -848K | -18.59M | 6.43M | 12.21M | 2.1M | -938K | -53.98M | 41.88M | -4.42M | -7.72M | 7.51M | -7.11M | -5.14M |
| Free Cash Flow | -16.79M | 5.85M | -10.89M | -10.1M | -13.48M | -9.56M | -9.56M | -8.71M | -10.47M | -6.38M | -7.3M | -9.91M | -8.25M | -6.45M | -8.62M | -6.18M | -7.09M | -6.23M | -7.24M | -7.9M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -24.59% | 161.17% | -13.98% | -15.96% | -28.76% | -49.77% | -30.96% | 12.14% | -26.81% | 1.02% | 15.34% | -60.54% | -16.38% | -3.5% | -19.03% | 21.8% | 6.41% | 30.24% | -3.71% | 6.51% |
| FCF per Share | -0.12 | 0.04 | -0.08 | -0.08 | -0.11 | -0.09 | -0.09 | -0.09 | -0.11 | -0.06 | -0.07 | -0.10 | -0.08 | -0.07 | -0.13 | -0.10 | -0.23 | -0.29 | -0.34 | -0.39 |
| FCF Conversion (FCF/Net Income) | 1.27x | 0.92x | 0.92x | 0.82x | 1.30x | 0.84x | 0.72x | 0.70x | 0.96x | 0.81x | 0.95x | 1.38x | 1.28x | 1.15x | 1.04x | 0.77x | 0.97x | 0.73x | 1.00x | 0.81x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |